US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vaxcyte, Inc.

34.28

-1.1100-3.14%

Post-market: 34.280.00000.00%16:43 EDT

Volume:1.61M

Turnover:55.81M

Market Cap:4.42B

PE:-9.01

High:35.56

Open:35.48

Low:34.17

Close:35.39

Loading ...

Overview Company News Filings

Vaxcyte Inc (PCVX) Q4 2024 Earnings Call Highlights: Strong Financial Health and Promising ...

Vaxcyte’s Promising Growth in the PCV Market: Analyst Recommends Buy Rating

Vaxcyte Inc reports results for the quarter ended December 31 - Earnings Summary

Vaxcyte 2024 Loss Narrows

MT Newswires Live

Earnings Flash (PCVX) Vaxcyte 2024 Loss Per Share $-3.80 vs. FactSet Est Loss of $-4.16

MT Newswires Live

Vaxcyte, Inc. (PCVX): Among the Stocks That Will Go to The Moon According to Analysts

Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Q32 Bio (QTTB) and Vaxcyte (PCVX)

Vaxcyte Price Target Maintained With a $14.00/Share by Needham

Why Vaxcyte, Inc. (PCVX) Is Among the Best Healthcare Stocks To Buy According to Analysts

Vaxcyte’s Promising Market Position and Innovative Approach Justify Buy Rating

Vaxcyte advances second stage of Phase 2 study evaluating VAX-31

Analysts Have Conflicting Sentiments on These Healthcare Companies: Molina Healthcare (MOH), Roche Holding AG (OtherRHHVF) and Vaxcyte (PCVX)

Vaxcyte Advances Phase 2 Study on Infant Pneumococcal Disease Prevention to Final Stage

MT Newswires Live

Vaxcyte Inc - Remains on Track to Announce Vax-24 Phase 2 Infant Study Topline Data From Primary Immunization Series by End of Q1 of 2025

THOMSON REUTERS

Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating Vax-31 for the Prevention of Invasive Pneumococcal Disease in Infants

THOMSON REUTERS

MRK Gets Positive CHMP Nod for 21-Valent Pneumococcal Jab Capvaxive

Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference

Why Vaxcyte, Inc. (PCVX) Is One of the Best Russell 2000 Stocks to Invest in According to Analysts?

Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III

Is Vaxcyte, Inc. (PCVX) the Best Performing Biotech Stock in 2024?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PCVX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PCVX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PCVX\",,,,,undefined,":{"symbol":"PCVX","market":"US","secType":"STK","nameCN":"Vaxcyte, Inc.","latestPrice":34.28,"timestamp":1746475200000,"preClose":35.39,"halted":0,"volume":1613390,"hourTrading":{"tag":"盘后","latestPrice":34.28,"preClose":34.28,"latestTime":"16:43 EDT","volume":46889,"amount":1607359.67,"timestamp":1746477804021},"delay":0,"floatShares":119430733,"shares":128999351,"eps":-3.802762,"marketStatus":"Closed","change":-1.11,"latestTime":"05-05 16:00:00 EDT","open":35.48,"high":35.5572,"low":34.17,"amount":55809822.193500005,"amplitude":0.039198,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.802762,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746518400000},"marketStatusCode":5,"adr":0,"listingDate":1591934400000,"exchange":"NASDAQ","adjPreClose":35.39,"preHourTrading":{"tag":"盘前","latestPrice":35.3,"preClose":35.39,"latestTime":"09:17 EDT","volume":375,"amount":13217.800125,"timestamp":1746451031290},"postHourTrading":{"tag":"盘后","latestPrice":34.28,"preClose":34.28,"latestTime":"16:43 EDT","volume":46889,"amount":1607359.67,"timestamp":1746477804021},"volumeRatio":0.802986,"impliedVol":0.7582,"impliedVolPercentile":0.704},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PCVX\",,,,,undefined,":{"symbol":"PCVX","floatShares":119430733,"roa":"-14.47%","roe":"-20.41%","lyrEps":-3.802762,"volumeRatio":0.802986,"shares":128999351,"dividePrice":0,"high":35.5572,"amplitude":0.039198,"preClose":35.39,"low":34.17,"week52Low":27.66,"pbRate":"1.34","week52High":121.055,"institutionHeld":0,"latestPrice":34.28,"eps":-3.802762,"divideRate":0,"volume":1613390,"delay":0,"ttmEps":-3.802762,"open":35.48,"prevYearClose":81.86,"prevWeekClose":35.39,"prevMonthClose":35.84,"prevQuarterClose":37.76,"fiveDayClose":32.9,"twentyDayClose":31.6,"sixtyDayClose":89.015},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PCVX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514001154","title":"Vaxcyte Inc (PCVX) Q4 2024 Earnings Call Highlights: Strong Financial Health and Promising ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2514001154","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514001154?lang=en_us&edition=fundamental","pubTime":"2025-02-26 15:15","pubTimestamp":1740554107,"startTime":"0","endTime":"0","summary":"Cash Equivalents and Investments: $3.13 billion as of December 31, 2024.Net Proceeds from Equity Offerings: $2.2 billion in 2024.R&D Expenses: Increased due to development and manufacturing activities for adult and infant PCV programs.G&A Expenses: Increased primarily due to higher personnel costs.Capital and Facility Expenditures: $127.8 million in 2024 for manufacturing suite buildout, totaling $214.3 million to date.Cash Runway: Expected to fund operations through several key milestones over the next few years.FDA Breakthrough Therapy Designation: Granted for VAC 31 in adults in November 2024.GuruFocus has detected 3 Warning Signs with PCVX.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Vaxcyte Inc  reported strong financial health with $3.13 billion in cash equivalents and investments as of December 31, 2024.The company announced promising clinical data for its VAC 31 vaccine in adults, which is advancing to a Phase 3 program.Q: ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vaxcyte-inc-pcvx-q4-2024-071507951.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PCVX"],"gpt_icon":0},{"id":"2514690079","title":"Vaxcyte’s Promising Growth in the PCV Market: Analyst Recommends Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2514690079","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514690079?lang=en_us&edition=fundamental","pubTime":"2025-02-26 11:35","pubTimestamp":1740540918,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Tara Bancroft from TD Cowen maintained a Buy rating on Vaxcyte (PCVX – Research Report), with a price target of $13...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/vaxcytes-promising-growth-in-the-pcv-market-analyst-recommends-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/vaxcytes-promising-growth-in-the-pcv-market-analyst-recommends-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PCVX"],"gpt_icon":0},{"id":"2514029415","title":"Vaxcyte Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2514029415","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514029415?lang=en_us&edition=fundamental","pubTime":"2025-02-26 08:33","pubTimestamp":1740529992,"startTime":"0","endTime":"0","summary":"Vaxcyte Inc reports results for the quarter ended December 31 - Earnings SummaryVaxcyte Inc PCVX.OQ reported a quarterly adjusted loss of $1.01 per share for the quarter ended December 31, higher than","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nL5N3PH01G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCVX"],"gpt_icon":0},{"id":"2514304083","title":"Vaxcyte 2024 Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2514304083","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514304083?lang=en_us&edition=fundamental","pubTime":"2025-02-26 06:20","pubTimestamp":1740522017,"startTime":"0","endTime":"0","summary":"Vaxcyte  reported a full-year 2024 net loss late Tuesday of $3.80 per diluted share, narrower than a per-share loss of $4.14 a year earlier.Analysts polled by FactSet expected a per-share loss of $3.91.The company said it had cash, cash equivalents and investments of $3.13 billion as of Dec. 31, up from $1.24 billion a year earlier. Vaxcyte said the increase was mainly due to $2.2 billion in net proceeds from two follow-on financings last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","PCVX","LU0053671581.USD","IE0009354923.USD"],"gpt_icon":0},{"id":"2514645041","title":"Earnings Flash (PCVX) Vaxcyte 2024 Loss Per Share $-3.80 vs. FactSet Est Loss of $-4.16","url":"https://stock-news.laohu8.com/highlight/detail?id=2514645041","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514645041?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:12","pubTimestamp":1740517947,"startTime":"0","endTime":"0","summary":"Earnings Flash (PCVX) Vaxcyte 2024 Loss Per Share $-3.80 vs. FactSet Est Loss of $-4.16","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PCVX"],"gpt_icon":0},{"id":"2514012796","title":"Vaxcyte, Inc. (PCVX): Among the Stocks That Will Go to The Moon According to Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2514012796","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514012796?lang=en_us&edition=fundamental","pubTime":"2025-02-26 01:30","pubTimestamp":1740504618,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 15 Stocks That Will Go to The Moon According to Analysts.In this article, we are going to take a look at where Vaxcyte, Inc.  stands against the other stocks.While stocks initially fell based on worries regarding Trump tariffs on America’s major trading partners, major indexes recovered from their initial losses as the President delayed tariffs on Mexico. He agreed to a 30-day pause on tariffs on Mexico and Canada in return for the two countries bolstering border enforcement to halt fentanyl smuggling and money laundering.Reuters reported that Trump raising tariffs on steel and aluminum imports to a flat 25% pushed up share prices of US steelmakers. The chaos around tariffs doesn’t end here. According to CNN, the President is looking to pursue more tariffs. Trump has been keen on reciprocal tariffs and wants agencies to investigate plans for new reciprocal tariffs that would increase America’s revenue. He reiterated this keenness saying:. Why are we i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vaxcyte-inc-pcvx-among-stocks-173018027.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PCVX","TSYW.SI","MNQmain","USAW.SI","SQQQ","USJW.SI","BK4139","QID","NVIW.SI","NQmain","PSQ",".IXIC","IE0009354923.USD","LU0053671581.USD","QLD","TQQQ"],"gpt_icon":1},{"id":"2511626015","title":"Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Q32 Bio (QTTB) and Vaxcyte (PCVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2511626015","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511626015?lang=en_us&edition=fundamental","pubTime":"2025-02-13 13:40","pubTimestamp":1739425249,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Voyager Therapeutics (VYGR – Research Report), Q32...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-voyager-therapeutics-vygr-q32-bio-qttb-and-vaxcyte-pcvx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-voyager-therapeutics-vygr-q32-bio-qttb-and-vaxcyte-pcvx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QTTB","VYGR","BK4139","PCVX","BK4137","IE0009354923.USD","LU0053671581.USD","HCSG"],"gpt_icon":0},{"id":"2510388645","title":"Vaxcyte Price Target Maintained With a $14.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2510388645","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510388645?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:26","pubTimestamp":1739276760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PCVX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 11, 2025 07:26 ET (12:26 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCVX"],"gpt_icon":0},{"id":"2509409053","title":"Why Vaxcyte, Inc. (PCVX) Is Among the Best Healthcare Stocks To Buy According to Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2509409053","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509409053?lang=en_us&edition=fundamental","pubTime":"2025-02-08 22:22","pubTimestamp":1739024564,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts.In this article, we are going to take a look at where Vaxcyte, Inc.  stands against the other healthcare stocks.McKinsey reported that, since 2019,the US healthcare industry witnessed significant financial pressure. This is evidenced by the fact that industry EBITDA as a proportion of the National Health Expenditure has declined by an estimated 150 bps . This fall has impacted payers and providers. Notably, the payers’ estimated margins in 2024 might be at their lowest levels in a decade. While providers have been facing labor shortages, the inflationary pressures have not yet been fully absorbed in the broader healthcare system.Amidst these past trends, what does the future hold?What Lies Ahead for the US Healthcare Industry?To list the 12 Best Healthcare Stocks to Buy According to Analysts, we used a screener and filte","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-vaxcyte-inc-pcvx-among-142244093.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QID","SQQQ","LU0053671581.USD","BK4585","MNQmain","BK4139","TQQQ","IE0009354923.USD","BK4588","HST","BK4181","QLD","NVIW.SI","PSQ","BK4218","PCVX","TSYW.SI","USJW.SI","BK4137","HCSG","NQmain",".IXIC","USAW.SI"],"gpt_icon":1},{"id":"2509711599","title":"Vaxcyte’s Promising Market Position and Innovative Approach Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2509711599","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509711599?lang=en_us&edition=fundamental","pubTime":"2025-02-07 19:26","pubTimestamp":1738927597,"startTime":"0","endTime":"0","summary":"Vaxcyte (PCVX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Jason Gerberry from Bank of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/vaxcytes-promising-market-position-and-innovative-approach-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/vaxcytes-promising-market-position-and-innovative-approach-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PCVX"],"gpt_icon":0},{"id":"2509759542","title":"Vaxcyte advances second stage of Phase 2 study evaluating VAX-31","url":"https://stock-news.laohu8.com/highlight/detail?id=2509759542","media":"TipRanks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509759542?lang=en_us&edition=fundamental","pubTime":"2025-02-06 21:20","pubTimestamp":1738848027,"startTime":"0","endTime":"0","summary":"Vaxcyte  announced that the first study participants have been dosed in the second and final stage of the ongoing Phase 2 study of VAX-31 in healthy infants. Advancement to Stage 2 follows a blinded assessment of the Stage 1 safety and tolerability data per the study protocol. This study is evaluating the safety, tolerability and immunogenicity of VAX-31, a 31-valent pneumococcal conjugate vaccine candidate designed to prevent invasive pneumococcal disease, in healthy infants. The Company expects to share topline data from the primary three-dose immunization series of the study in mid-2026, followed by topline data from the booster dose approximately nine months later. The company said, “VAX-31 and VAX-24 Offer Potential to Protect Vulnerable Population by Providing Greater Coverage Against Both Currently Circulating and Historically Prevalent Strains Relative to Standard-Of-Care Pneumococcal Conjugate Vaccines ”。Leverage the power of TipRanks' Smart Score, a data-driven tool to help y","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/vaxcyte-advances-second-stage-phase-132027195.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vaxcyte-advances-second-stage-phase-132027195.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0053671581.USD","BK4139","PCVX","IE0009354923.USD"],"gpt_icon":0},{"id":"2509243187","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Molina Healthcare (MOH), Roche Holding AG (OtherRHHVF) and Vaxcyte (PCVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2509243187","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509243187?lang=en_us&edition=fundamental","pubTime":"2025-02-06 15:30","pubTimestamp":1738827035,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Molina Healthcare (MOH – Research Report), Roche H...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-molina-healthcare-moh-roche-holding-ag-otherrhhvf-and-vaxcyte-pcvx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-molina-healthcare-moh-roche-holding-ag-otherrhhvf-and-vaxcyte-pcvx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999014013.SGD","IE0009354923.USD","BK4139","MOH","SG9999014021.USD","LU0053671581.USD","PCVX","BK4585","BK4210","BK4588","SG9999014005.SGD","SG9999014039.USD","AG","BK4154","BK4532"],"gpt_icon":0},{"id":"2509280429","title":"Vaxcyte Advances Phase 2 Study on Infant Pneumococcal Disease Prevention to Final Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2509280429","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509280429?lang=en_us&edition=fundamental","pubTime":"2025-02-05 23:22","pubTimestamp":1738768973,"startTime":"0","endTime":"0","summary":"Vaxcyte  said Wednesday its ongoing phase 2 study assessing VAX-31 for the prevention of invasive pneumococcal disease in infants is advancing to its second and final stage.The company said participants who received VAX-31 in the first stage will continue the standard dosing regimen as part of the second stage.Vaxcyte said it expects to release topline data from the study's primary three-dose immunization series in the middle of next year, followed by topline data from the booster dose about nine months later.In infants, the VAX-31 was designed to cover about 94% of invasive pneumococcal disease and roughly 93% of acute otitis media caused by streptococcus pneumoniae in children under five years old in the United States.Shares of Vaxcyte were up nearly 3% in recent trading.Price: 88.88, Change: +2.37, Percent Change: +2.73","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SSI","LU0053671581.USD","BK4139","PCVX","IE0009354923.USD"],"gpt_icon":0},{"id":"2509504283","title":"Vaxcyte Inc - Remains on Track to Announce Vax-24 Phase 2 Infant Study Topline Data From Primary Immunization Series by End of Q1 of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2509504283","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509504283?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:03","pubTimestamp":1738760585,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nFWN3OW20G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053671581.USD","PCVX","BK4139","IE0009354923.USD"],"gpt_icon":0},{"id":"2509228350","title":"Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating Vax-31 for the Prevention of Invasive Pneumococcal Disease in Infants","url":"https://stock-news.laohu8.com/highlight/detail?id=2509228350","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509228350?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:03","pubTimestamp":1738760585,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nFWN3OW20G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053671581.USD","PCVX","IE0009354923.USD","BK4139"],"gpt_icon":0},{"id":"2508312972","title":"MRK Gets Positive CHMP Nod for 21-Valent Pneumococcal Jab Capvaxive","url":"https://stock-news.laohu8.com/highlight/detail?id=2508312972","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508312972?lang=en_us&edition=fundamental","pubTime":"2025-02-04 00:22","pubTimestamp":1738599720,"startTime":"0","endTime":"0","summary":"Merck MRK announced that the European Medicines Agency’s  Committee for Medicinal Products for Human Use  has recommended the approval of its 21-valent pneumococcal conjugate vaccine , Capvaxive, for the prevention of invasive pneumococcal disease  and pneumococcal pneumonia in individuals aged 18 years and above.The European Commission will now review the CHMP’s opinion and a final decision from the regulatory body is expected by the second quarter of 2025.The FDA approved Capvaxive for 21 serotypes, which account for 84% of all IPDs in older adults, in June 2024.Capvaxive targets serotypes that account for approximately 84% of all IPD in older adults  in the United States, including eight serotypes not covered by currently licensed vaccines.In the past year, shares of Merck have plunged 21.7% compared with the industry’s decrease of 2.6%.A potential approval in the EU will mark the fourth authorization of Capvaxive for the prevention of IPD and pneumococcal pneumonia in adults.Once t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mrk-gets-positive-chmp-nod-162200228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1162221912.USD","IE0002141913.USD","LU1066051225.USD","LU1093756168.USD","MRK","SG9999015341.SGD","SG9999002224.SGD","SG9999002232.USD","LU1934455277.USD","LU1989772840.SGD","LU1974910355.USD","SG9999014542.SGD","LU0106261372.USD","LU0289739699.SGD","CHMP","LU1430594728.SGD","LU2106854487.HKD","LU1066051811.HKD","PCVX","LU1057294990.SGD","IE000M9KFDE8.USD","IE00BJT1NW94.SGD","BK4585","LU1571399168.USD","SG9999014559.SGD","LU0965509283.SGD","IE00BSNM7G36.USD","LU1116320901.HKD","LU1934455194.USD","SNY","LU0456855351.SGD","LU0006306889.USD","IE0009354923.USD","LU0985481810.HKD","LU1291159041.SGD","BK4592","SG9999014575.USD","BK4516","LU0861579265.USD","LU1894683264.USD","LU1116320737.USD","PFE","SG9999011175.SGD","LU0320765489.SGD","LU1093756325.SGD","IE00BLSP4239.USD","LU0321505868.SGD","LU2089984988.USD","SGXZ57979304.SGD","LU1037948897.HKD"],"gpt_icon":1},{"id":"2507637603","title":"Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2507637603","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507637603?lang=en_us&edition=fundamental","pubTime":"2025-01-31 05:05","pubTimestamp":1738271100,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., Jan.  30, 2025  (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the conse","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/30/3018412/0/en/Vaxcyte-to-Present-at-the-Guggenheim-SMID-Cap-Biotech-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMID","LU0053671581.USD","BK4011","IE0009354923.USD","BK4139","PCVX"],"gpt_icon":0},{"id":"2504480254","title":"Why Vaxcyte, Inc. (PCVX) Is One of the Best Russell 2000 Stocks to Invest in According to Analysts?","url":"https://stock-news.laohu8.com/highlight/detail?id=2504480254","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504480254?lang=en_us&edition=fundamental","pubTime":"2025-01-19 06:50","pubTimestamp":1737240630,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Best Russell 2000 Stocks to Invest in According to Analysts.In this article, we are going to take a look at where Vaxcyte, Inc.  stands against other best Russell 2000 stocks to invest in according to analysts.The Russell 2000 Index is a widely followed benchmark that tracks the performance of small-cap companies in the United States. This index includes the smallest 2,000 companies, ranging from a few hundred million to a few billion dollars in market capitalization. These companies are often seen as more growth-oriented and can be more volatile compared to their large-cap counterparts. Investors and analysts use the performance of the Russell 2000 Index to gauge the health and trends of the small-cap segment of the U.S. equity market, which can provide insights into broader economic conditions and investor sentiment toward smaller, potentially higher-growth companies.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-vaxcyte-inc-pcvx-one-225030421.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4592","IE00BLSP4239.USD","SG9999013999.USD","LU0234572021.USD","SG9999011175.SGD","LU0456855351.SGD","LU0306806265.USD","SG9999003800.SGD","SGXZ57979304.SGD","BK4139","MNQmain","LU0053671581.USD","USJW.SI","BK4581","IE0002270589.USD","LU0225284248.USD","IE00B19Z3B42.SGD","BK4550","LU0985481810.HKD","PFE","IE00BBT3K403.USD","IE0009354923.USD","QLD","IE000M9KFDE8.USD","LU0122379950.USD","LU0170899867.USD","LU1066051498.USD","LU0058720904.USD","BK4599","BK4585","SG9999001176.SGD","LU0289739699.SGD",".IXIC","USAW.SI","PSQ","TQQQ","NVIW.SI","BK4568","LU0868494617.USD","LU1894683348.USD","PCVX","QID","LU0321505868.SGD","LU1883839398.USD","TSYW.SI","LU1057294990.SGD","NQmain","LU1066053197.SGD","SQQQ"],"gpt_icon":1},{"id":"2493779256","title":"Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III","url":"https://stock-news.laohu8.com/highlight/detail?id=2493779256","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493779256?lang=en_us&edition=fundamental","pubTime":"2024-12-24 01:42","pubTimestamp":1734975720,"startTime":"0","endTime":"0","summary":"Sanofi SNY and its partner SK bioscience announced that they have expanded their agreement to develop, license and commercialize next-generation pneumococcal conjugate vaccines  for treating invasive pneumococcal disease  in pediatric and adult patient populations.The latest deal builds on the existing collaboration between SNY and SK bioscience to develop and commercialize a 21-valent PCV  for the pediatric patient population.Sanofi also said that the companies commenced a phase III program for the PCV21 pediatric vaccine last week. Per management, this is the first-ever PCV containing more than 20 serotypes to enter a phase III study targeting infants and toddlers.Year to date, shares of Sanofi have lost 4% against the industry’s growth of 1.4%.Per the expanded collaboration agreement, Sanofi and SK bioscience will jointly fund all research and development costs to support the launch of PCV21 and next-generation vaccines.Pfizer PFE is a key player in the PCV vaccine space.Small vacci","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MPLv._QOfr9ekgf5qyZbUA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4c89fa4c828d913dc49739912177a966","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MPLv._QOfr9ekgf5qyZbUA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4c89fa4c828d913dc49739912177a966"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sanofis-21-valent-pneumococcal-vaccine-174200443.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1061106388.HKD","LU0306807586.USD","LU1037948897.HKD","SG9999014575.USD","LU1057294990.SGD","III","LU1116320901.HKD","BK4585","BK4592","LU1430594728.SGD","SNYNF","LU0070302665.USD","LU0058720904.USD","LU0225284248.USD","BK4550","PCVX","LU0053671581.USD","LU1066051498.USD","SNY","IE00BBT3K403.USD","LU1116320737.USD","LU0320765489.SGD","SG9999001176.SGD","LU0306806265.USD","LU2361044865.SGD","LU1989771016.USD","IE00BN8TJ469.HKD","LU0203347892.USD","IE0002270589.USD","SG9999013999.USD","LU0211331839.USD","LU1093756325.SGD","LU1989772840.SGD","LU0225771236.USD","MRK","LU2361044949.HKD","LU0965508806.USD","BK4139","LU2361045086.USD","LU2106854487.HKD","LU2089984988.USD","IE00BJT1NW94.SGD","LU0265550946.USD","LU2468319806.SGD","LU0289739699.SGD","SGXZ57979304.SGD","PFE","LU0456855351.SGD","LU0861579265.USD","LU1974910355.USD"],"gpt_icon":1},{"id":"2493976768","title":"Is Vaxcyte, Inc. (PCVX) the Best Performing Biotech Stock in 2024?","url":"https://stock-news.laohu8.com/highlight/detail?id=2493976768","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493976768?lang=en_us&edition=fundamental","pubTime":"2024-12-23 23:11","pubTimestamp":1734966676,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Best Performing Biotech Stocks in 2024.In this article, we are going to take a look at where Vaxcyte, Inc.  stands against the other biotech stocks.Biotech businesses have been further challenged by volatile market conditions, which have led several of them to reduce programs and lay off huge numbers of employees to save money. Although recent rate cuts may assist in resurrecting scientific initiatives, analysts like Jared Holz point out that it is still challenging to forecast their consequences. Holz also points out that the performance of biotech companies is increasingly matching that of small-cap stocks, indicating a change in market dynamics. Biotech may increase if small-cap stocks trade well, but stagnation could result from momentum loss. Interest rates and biotech success have a relatively recent relationship that emerged after the pandemic when enterprises with a therapeutic focus recei","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/3vgCyxkyGGiWGglK.iJ41A--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/1e5f211aa792b374d86fa2294581b04b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/3vgCyxkyGGiWGglK.iJ41A--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/1e5f211aa792b374d86fa2294581b04b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vaxcyte-inc-pcvx-best-performing-151116138.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CAGR","USAW.SI","PSQ","QID","QLD","IE0009354923.USD","BK4159",".IXIC","PCVX","TQQQ","TSYW.SI","NQmain","SQQQ","MNQmain","LU0053671581.USD","BK4139","USJW.SI","NVIW.SI"],"gpt_icon":1}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":87,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PCVX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-25","symbol":"PCVX","fiscalQuarterEnding":"2024/12","expectedEps":-1.32,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"post","actualEps":-1.02},{"market":"US","date":"2024-11-05","symbol":"PCVX","fiscalQuarterEnding":"2024/09","expectedEps":-0.98,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730782800000,"reportTimeType":"post","actualEps":-0.83},{"market":"US","date":"2024-08-06","symbol":"PCVX","fiscalQuarterEnding":"2024/06","expectedEps":-1.14,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"post","actualEps":-1.1},{"market":"US","date":"2024-05-08","symbol":"PCVX","fiscalQuarterEnding":"2024/03","expectedEps":-1.11,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"post","actualEps":-0.85},{"market":"US","date":"2024-02-27","symbol":"PCVX","fiscalQuarterEnding":"2023/12","expectedEps":-0.9,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709010000000,"reportTimeType":"post","actualEps":-1.82}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PCVX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PCVX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":10,"updateTime":1734753600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PCVX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PCVX","date":"2025-05-02","current":-9.79882,"percent":0.969064,"low":-38.84884,"twenty":-21.209423,"median":-17.273877,"eighty":-12.990005,"high":-2.134487,"avg":-18.009802,"sd":6.176005,"marketCap":4545937129},"quantilePoints":[{"date":"2020-06-12","current":-2.134487,"twenty":-2.203215,"median":-2.203215,"eighty":-2.161978,"marketCap":107309192},{"date":"2020-06-19","current":-35.771204,"twenty":-34.350446,"median":-30.323462,"eighty":-2.203215,"marketCap":1798361519},{"date":"2020-06-26","current":-33.188009,"twenty":-34.065892,"median":-33.188009,"eighty":-12.301459,"marketCap":1668493945},{"date":"2020-07-02","current":-30.261732,"twenty":-33.70263,"median":-32.411032,"eighty":-28.011406,"marketCap":1521378334},{"date":"2020-07-10","current":-29.848017,"twenty":-33.601724,"median":-30.952939,"eighty":-29.147729,"marketCap":1500579231},{"date":"2020-07-17","current":-29.262762,"twenty":-33.196081,"median":-29.999377,"eighty":-27.751068,"marketCap":1471156109},{"date":"2020-07-24","current":-31.099253,"twenty":-33.196081,"median":-30.761218,"eighty":-28.974171,"marketCap":1563483837},{"date":"2020-07-31","current":-31.694599,"twenty":-33.109302,"median":-31.099253,"eighty":-29.077095,"marketCap":1593414254},{"date":"2020-08-07","current":-35.629936,"twenty":-33.70263,"median":-31.563421,"eighty":-29.268816,"marketCap":1791259386},{"date":"2020-08-14","current":-34.987622,"twenty":-33.979112,"median":-31.694599,"eighty":-29.268816,"marketCap":2568091419},{"date":"2020-08-21","current":-35.653656,"twenty":-34.306048,"median":-32.101112,"eighty":-29.32936,"marketCap":2616978347},{"date":"2020-08-28","current":-30.561268,"twenty":-34.306048,"median":-32.184727,"eighty":-29.502919,"marketCap":2243197046},{"date":"2020-09-04","current":-26.953581,"twenty":-34.270783,"median":-31.795505,"eighty":-29.32936,"marketCap":1978392854},{"date":"2020-09-11","current":-27.446169,"twenty":-34.162016,"median":-31.563421,"eighty":-28.960044,"marketCap":2014548811},{"date":"2020-09-18","current":-35.015373,"twenty":-34.286898,"median":-31.644146,"eighty":-28.960044,"marketCap":2570128375},{"date":"2020-09-25","current":-36.076865,"twenty":-34.963956,"median":-31.956955,"eighty":-29.030678,"marketCap":2648041916},{"date":"2020-10-02","current":-33.89144,"twenty":-34.987622,"median":-32.269763,"eighty":-29.262762,"marketCap":2487631684},{"date":"2020-10-09","current":-33.717993,"twenty":-34.987622,"median":-32.72384,"eighty":-29.293034,"marketCap":2474900713},{"date":"2020-10-16","current":-34.467282,"twenty":-34.963956,"median":-33.188009,"eighty":-29.474665,"marketCap":2529898507},{"date":"2020-10-23","current":-30.214375,"twenty":-34.758672,"median":-32.72384,"eighty":-29.474665,"marketCap":2217735104},{"date":"2020-10-30","current":-25.926778,"twenty":-34.599101,"median":-32.411032,"eighty":-29.125131,"marketCap":1903025507},{"date":"2020-11-06","current":-24.962416,"twenty":-34.467282,"median":-32.101112,"eighty":-28.084452,"marketCap":1832241310},{"date":"2020-11-13","current":-23.298023,"twenty":-34.3787,"median":-31.694599,"eighty":-27.349039,"marketCap":1936089018},{"date":"2020-11-20","current":-21.287036,"twenty":-34.308066,"median":-31.44866,"eighty":-26.294485,"marketCap":1768973965},{"date":"2020-11-27","current":-21.237987,"twenty":-34.299993,"median":-31.2522,"eighty":-25.893476,"marketCap":1764897989},{"date":"2020-12-04","current":-19.294442,"twenty":-34.289113,"median":-30.957984,"eighty":-25.529933,"marketCap":1603387405},{"date":"2020-12-11","current":-19.006282,"twenty":-34.281348,"median":-30.363875,"eighty":-25.223279,"marketCap":1579441041},{"date":"2020-12-18","current":-18.70586,"twenty":-34.263309,"median":-30.214375,"eighty":-22.668976,"marketCap":1554475682},{"date":"2020-12-24","current":-17.14244,"twenty":-34.200868,"median":-29.999377,"eighty":-21.424371,"marketCap":1424553919},{"date":"2020-12-31","current":-16.290223,"twenty":-34.134265,"median":-29.848017,"eighty":-21.223273,"marketCap":1353733821},{"date":"2021-01-08","current":-16.069505,"twenty":-34.078762,"median":-29.631069,"eighty":-20.205517,"marketCap":1335391925},{"date":"2021-01-15","current":-15.756821,"twenty":-34.04498,"median":-29.474665,"eighty":-19.629198,"marketCap":1309407572},{"date":"2021-01-22","current":-15.413482,"twenty":-34.004261,"median":-29.262762,"eighty":-19.206155,"marketCap":1280875734},{"date":"2021-01-29","current":-15.039487,"twenty":-33.916416,"median":-29.077905,"eighty":-18.299984,"marketCap":1249796410},{"date":"2021-02-05","current":-14.739065,"twenty":-33.902541,"median":-28.805989,"eighty":-17.635378,"marketCap":1224831052},{"date":"2021-02-12","current":-16.044981,"twenty":-33.89144,"median":-27.60013,"eighty":-17.201299,"marketCap":1333353936},{"date":"2021-02-19","current":-15.830394,"twenty":-33.89144,"median":-27.397604,"eighty":-16.866543,"marketCap":1315521538},{"date":"2021-02-26","current":-14.444774,"twenty":-33.793445,"median":-26.851107,"eighty":-16.541596,"marketCap":1200375191},{"date":"2021-03-05","current":-14.567395,"twenty":-33.717993,"median":-26.242451,"eighty":-16.167602,"marketCap":1210565133},{"date":"2021-03-12","current":-16.173733,"twenty":-33.70263,"median":-25.926778,"eighty":-15.989801,"marketCap":1344053376},{"date":"2021-03-19","current":-15.57902,"twenty":-33.70263,"median":-25.683953,"eighty":-15.977539,"marketCap":1294632156},{"date":"2021-03-26","current":-14.567395,"twenty":-33.662491,"median":-25.468879,"eighty":-15.854918,"marketCap":1210565133},{"date":"2021-04-01","current":-12.041287,"twenty":-33.584786,"median":-25.323184,"eighty":-15.836525,"marketCap":1074287463},{"date":"2021-04-09","current":-11.632815,"twenty":-33.392638,"median":-24.94854,"eighty":-15.78625,"marketCap":1037844840},{"date":"2021-04-16","current":-10.487676,"twenty":-33.311269,"median":-22.709441,"eighty":-15.55327,"marketCap":935679026},{"date":"2021-04-23","current":-10.919386,"twenty":-33.218824,"median":-21.912403,"eighty":-15.299444,"marketCap":974194902},{"date":"2021-04-30","current":-10.689141,"twenty":-33.190027,"median":-21.287036,"eighty":-15.131453,"marketCap":953653102},{"date":"2021-05-07","current":-10.153821,"twenty":-33.084719,"median":-21.011138,"eighty":-15.018642,"marketCap":905893415},{"date":"2021-05-14","current":-11.86778,"twenty":-32.847359,"median":-20.348984,"eighty":-14.778304,"marketCap":988526765},{"date":"2021-05-21","current":-12.058997,"twenty":-32.68146,"median":-19.922875,"eighty":-14.531835,"marketCap":1004454171},{"date":"2021-05-28","current":-12.996577,"twenty":-32.555937,"median":-19.594864,"eighty":-14.291498,"marketCap":1082549841},{"date":"2021-06-04","current":-13.502376,"twenty":-32.459267,"median":-19.294442,"eighty":-13.543087,"marketCap":1124680399},{"date":"2021-06-11","current":-13.576395,"twenty":-32.326271,"median":-18.856071,"eighty":-13.573928,"marketCap":1130845847},{"date":"2021-06-18","current":-13.249476,"twenty":-32.218741,"median":-18.276686,"eighty":-13.543087,"marketCap":1103615120},{"date":"2021-06-25","current":-14.803884,"twenty":-32.08439,"median":-17.737153,"eighty":-13.491436,"marketCap":1233089520},{"date":"2021-07-02","current":-14.057522,"twenty":-31.944846,"median":-17.553221,"eighty":-13.501662,"marketCap":1170921256},{"date":"2021-07-09","current":-13.823127,"twenty":-31.815686,"median":-17.265061,"eighty":-13.436992,"marketCap":1151397339},{"date":"2021-07-16","current":-13.261813,"twenty":-31.674418,"median":-17.124047,"eighty":-13.30129,"marketCap":1104642695},{"date":"2021-07-23","current":-13.890978,"twenty":-31.579566,"median":-16.774577,"eighty":-13.380244,"marketCap":1157048999},{"date":"2021-07-30","current":-13.372842,"twenty":-31.455467,"median":-16.578383,"eighty":-13.387646,"marketCap":1113890866},{"date":"2021-08-06","current":-14.877903,"twenty":-31.365164,"median":-16.541596,"eighty":-13.436992,"marketCap":1239254967},{"date":"2021-08-13","current":-15.677143,"twenty":-31.259955,"median":-16.406713,"eighty":-13.486858,"marketCap":1358487192},{"date":"2021-08-20","current":-12.906692,"twenty":-31.167757,"median":-16.243279,"eighty":-13.436992,"marketCap":1118416463},{"date":"2021-08-27","current":-16.044529,"twenty":-31.042745,"median":-16.118553,"eighty":-13.486858,"marketCap":1390322658},{"date":"2021-09-03","current":-15.454303,"twenty":-30.799298,"median":-16.056575,"eighty":-13.501305,"marketCap":1339177155},{"date":"2021-09-10","current":-15.755439,"twenty":-30.533651,"median":-16.044529,"eighty":-13.509778,"marketCap":1365271800},{"date":"2021-09-17","current":-15.273621,"twenty":-30.399459,"median":-16.002108,"eighty":-13.545554,"marketCap":1323520369},{"date":"2021-09-24","current":-15.526575,"twenty":-30.296,"median":-15.971408,"eighty":-13.571461,"marketCap":1345439870},{"date":"2021-10-01","current":-15.797598,"twenty":-30.252261,"median":-15.938491,"eighty":-13.585031,"marketCap":1368925050},{"date":"2021-10-08","current":-14.544872,"twenty":-30.181073,"median":-15.881916,"eighty":-13.619573,"marketCap":1260371329},{"date":"2021-10-15","current":-14.701463,"twenty":-30.038168,"median":-15.83959,"eighty":-13.634377,"marketCap":1273940544},{"date":"2021-10-22","current":-13.6776,"twenty":-29.986874,"median":-15.836525,"eighty":-13.619573,"marketCap":1185218753},{"date":"2021-10-29","current":-14.093168,"twenty":-29.919091,"median":-15.822921,"eighty":-13.619573,"marketCap":1221229362},{"date":"2021-11-05","current":-15.243508,"twenty":-29.833872,"median":-15.797598,"eighty":-13.623951,"marketCap":1320910904},{"date":"2021-11-12","current":-15.134436,"twenty":-29.751073,"median":-15.774414,"eighty":-13.643873,"marketCap":1396166847},{"date":"2021-11-19","current":-12.994444,"twenty":-29.640151,"median":-15.762952,"eighty":-13.643873,"marketCap":1198750438},{"date":"2021-11-26","current":-11.363701,"twenty":-29.615934,"median":-15.755439,"eighty":-13.576395,"marketCap":1048312800},{"date":"2021-12-03","current":-11.054718,"twenty":-29.492837,"median":-15.662087,"eighty":-13.502376,"marketCap":1019808827},{"date":"2021-12-10","current":-12.439419,"twenty":-29.474665,"median":-15.610894,"eighty":-13.409852,"marketCap":1147548856},{"date":"2021-12-17","current":-12.679739,"twenty":-29.293034,"median":-15.552798,"eighty":-13.261813,"marketCap":1169718613},{"date":"2021-12-23","current":-13.82412,"twenty":-29.268816,"median":-15.502485,"eighty":-13.260579,"marketCap":1275288885},{"date":"2021-12-31","current":-13.612409,"twenty":-29.21926,"median":-15.450268,"eighty":-13.25441,"marketCap":1255758385},{"date":"2022-01-07","current":-13.612409,"twenty":-29.141782,"median":-15.412813,"eighty":-13.260579,"marketCap":1255758385},{"date":"2022-01-14","current":-11.644212,"twenty":-29.049569,"median":-15.345894,"eighty":-13.248242,"marketCap":1074190192},{"date":"2022-01-21","current":-10.46361,"twenty":-28.988298,"median":-15.279644,"eighty":-13.177704,"marketCap":965278474},{"date":"2022-01-28","current":-10.685347,"twenty":-28.867611,"median":-15.231462,"eighty":-13.055331,"marketCap":985733974},{"date":"2022-02-04","current":-10.739283,"twenty":-28.373067,"median":-15.186632,"eighty":-12.971556,"marketCap":990709637},{"date":"2022-02-11","current":-11.841978,"twenty":-27.884642,"median":-15.154572,"eighty":-12.789242,"marketCap":1092434287},{"date":"2022-02-18","current":-12.213538,"twenty":-27.569868,"median":-15.134436,"eighty":-12.66337,"marketCap":1126711071},{"date":"2022-02-25","current":-13.543962,"twenty":-27.447762,"median":-15.081457,"eighty":-12.60844,"marketCap":1249444073},{"date":"2022-03-04","current":-12.902121,"twenty":-27.407317,"median":-15.056803,"eighty":-12.655185,"marketCap":1291205520},{"date":"2022-03-11","current":-13.667358,"twenty":-27.190856,"median":-15.039487,"eighty":-12.697912,"marketCap":1367788141},{"date":"2022-03-18","current":-14.629531,"twenty":-26.912591,"median":-15.031927,"eighty":-12.729886,"marketCap":1464079526},{"date":"2022-03-25","current":-13.481675,"twenty":-26.806708,"median":-15.008832,"eighty":-12.75445,"marketCap":1349205593},{"date":"2022-04-01","current":-13.397274,"twenty":-26.56186,"median":-15.002599,"eighty":-12.786391,"marketCap":1340758981},{"date":"2022-04-08","current":-14.438221,"twenty":-26.252858,"median":-14.954417,"eighty":-12.801505,"marketCap":1444933870},{"date":"2022-04-14","current":-13.802399,"twenty":-26.169603,"median":-14.89419,"eighty":-12.812618,"marketCap":1381302722},{"date":"2022-04-22","current":-14.501863,"twenty":-26.054435,"median":-14.847747,"eighty":-12.834599,"marketCap":1451302975},{"date":"2022-04-29","current":-14.043604,"twenty":-25.893476,"median":-14.832093,"eighty":-12.903035,"marketCap":1405441800},{"date":"2022-05-06","current":-14.078409,"twenty":-25.749169,"median":-14.8193,"eighty":-12.912799,"marketCap":1408924928},{"date":"2022-05-13","current":-11.643665,"twenty":-25.696441,"median":-14.803884,"eighty":-12.798225,"marketCap":1372124372},{"date":"2022-05-20","current":-12.974793,"twenty":-25.63955,"median":-14.78197,"eighty":-12.727529,"marketCap":1528988570},{"date":"2022-05-27","current":-12.910464,"twenty":-25.529933,"median":-14.739625,"eighty":-12.727529,"marketCap":1521407772},{"date":"2022-06-03","current":-10.83707,"twenty":-25.468879,"median":-14.701463,"eighty":-12.638816,"marketCap":1277072833},{"date":"2022-06-10","current":-9.322849,"twenty":-25.378687,"median":-14.632372,"eighty":-12.529434,"marketCap":1098632519},{"date":"2022-06-17","current":-9.990888,"twenty":-25.323184,"median":-14.567395,"eighty":-12.411304,"marketCap":1177356187},{"date":"2022-06-24","current":-9.649446,"twenty":-25.295433,"median":-14.559871,"eighty":-12.356612,"marketCap":1137119646},{"date":"2022-07-01","current":-10.733153,"twenty":-25.027632,"median":-14.544872,"eighty":-12.280659,"marketCap":1264826929},{"date":"2022-07-08","current":-11.802015,"twenty":-24.945765,"median":-14.531772,"eighty":-12.208936,"marketCap":1390784797},{"date":"2022-07-15","current":-12.316652,"twenty":-23.952679,"median":-14.512216,"eighty":-12.136983,"marketCap":1451431178},{"date":"2022-07-22","current":-11.287377,"twenty":-22.944874,"median":-14.465518,"eighty":-12.125268,"marketCap":1330138416},{"date":"2022-07-29","current":-11.420985,"twenty":-22.588047,"median":-14.443856,"eighty":-12.103448,"marketCap":1345883150},{"date":"2022-08-05","current":-12.831289,"twenty":-22.429865,"median":-14.436004,"eighty":-12.081262,"marketCap":1512077560},{"date":"2022-08-12","current":-10.957188,"twenty":-21.819211,"median":-14.406349,"eighty":-11.987006,"marketCap":1563546932},{"date":"2022-08-19","current":-10.807545,"twenty":-21.413336,"median":-14.344728,"eighty":-11.893983,"marketCap":1542193484},{"date":"2022-08-26","current":-11.55576,"twenty":-21.328727,"median":-14.308806,"eighty":-11.856598,"marketCap":1648960725},{"date":"2022-09-02","current":-10.965502,"twenty":-21.257607,"median":-14.253853,"eighty":-11.805991,"marketCap":1564733234},{"date":"2022-09-09","current":-11.759441,"twenty":-21.228177,"median":-14.197019,"eighty":-11.782001,"marketCap":1678025140},{"date":"2022-09-16","current":-10.861583,"twenty":-21.051603,"median":-14.162382,"eighty":-11.765767,"marketCap":1549904451},{"date":"2022-09-23","current":-10.325363,"twenty":-20.642048,"median":-14.149216,"eighty":-11.72881,"marketCap":1473387928},{"date":"2022-09-30","current":-9.976196,"twenty":-20.374734,"median":-14.130616,"eighty":-11.651023,"marketCap":1423563216},{"date":"2022-10-07","current":-10.00945,"twenty":-20.25334,"median":-14.108764,"eighty":-11.612104,"marketCap":1428308426},{"date":"2022-10-14","current":-10.208974,"twenty":-20.041205,"median":-14.087145,"eighty":-11.550385,"marketCap":1456779691},{"date":"2022-10-21","current":-8.554588,"twenty":-19.925941,"median":-14.050563,"eighty":-11.479299,"marketCap":1220705457},{"date":"2022-10-28","current":-23.436216,"twenty":-20.25334,"median":-14.078409,"eighty":-11.519454,"marketCap":3344254210},{"date":"2022-11-04","current":-23.236229,"twenty":-21.228177,"median":-14.098831,"eighty":-11.528532,"marketCap":3315716985},{"date":"2022-11-11","current":-20.162877,"twenty":-21.051603,"median":-14.115937,"eighty":-11.5396,"marketCap":3508300306},{"date":"2022-11-18","current":-19.99039,"twenty":-20.642048,"median":-14.139963,"eighty":-11.550385,"marketCap":3478287831},{"date":"2022-11-25","current":-19.972233,"twenty":-20.383318,"median":-14.156214,"eighty":-11.558496,"marketCap":3475128624},{"date":"2022-12-02","current":-20.385295,"twenty":-20.609529,"median":-14.168551,"eighty":-11.575016,"marketCap":3547000602},{"date":"2022-12-09","current":-19.241431,"twenty":-20.426561,"median":-14.229892,"eighty":-11.597521,"marketCap":3347970508},{"date":"2022-12-16","current":-20.789279,"twenty":-20.651289,"median":-14.285748,"eighty":-11.6052,"marketCap":3617292976},{"date":"2022-12-23","current":-21.184185,"twenty":-20.782016,"median":-14.325872,"eighty":-11.6332,"marketCap":3686005747},{"date":"2022-12-30","current":-21.765195,"twenty":-20.907297,"median":-14.359697,"eighty":-11.634738,"marketCap":3787100398},{"date":"2023-01-06","current":-21.175106,"twenty":-21.113374,"median":-14.412372,"eighty":-11.64188,"marketCap":3684426143},{"date":"2023-01-13","current":-20.25366,"twenty":-20.996264,"median":-14.438221,"eighty":-11.644103,"marketCap":3524096345},{"date":"2023-01-20","current":-20.471539,"twenty":-20.932716,"median":-14.443856,"eighty":-11.654429,"marketCap":3562006839},{"date":"2023-01-27","current":-20.957227,"twenty":-21.021683,"median":-14.465518,"eighty":-11.668106,"marketCap":3646515649},{"date":"2023-02-03","current":-20.539626,"twenty":-20.962674,"median":-14.501863,"eighty":-11.693283,"marketCap":3573853869},{"date":"2023-02-10","current":-19.858755,"twenty":-20.927269,"median":-14.524498,"eighty":-11.719479,"marketCap":3455383575},{"date":"2023-02-17","current":-20.072094,"twenty":-20.907297,"median":-14.544872,"eighty":-11.729321,"marketCap":3492504267},{"date":"2023-02-24","current":-18.92823,"twenty":-20.885509,"median":-14.550984,"eighty":-11.733669,"marketCap":3293474173},{"date":"2023-03-03","current":-15.234288,"twenty":-20.849196,"median":-14.56482,"eighty":-11.744206,"marketCap":3404634746},{"date":"2023-03-10","current":-13.543976,"twenty":-20.829775,"median":-14.567395,"eighty":-11.755294,"marketCap":3026875555},{"date":"2023-03-17","current":-13.461609,"twenty":-20.800999,"median":-14.555428,"eighty":-11.765767,"marketCap":3008467797},{"date":"2023-03-24","current":-13.551139,"twenty":-20.774754,"median":-14.544872,"eighty":-11.782001,"marketCap":3028476229},{"date":"2023-03-31","current":-13.422217,"twenty":-20.713022,"median":-14.524498,"eighty":-11.796077,"marketCap":2999664087},{"date":"2023-04-06","current":-13.475934,"twenty":-20.653105,"median":-14.50704,"eighty":-11.802778,"marketCap":3011669147},{"date":"2023-04-14","current":-13.074843,"twenty":-20.651289,"median":-14.481561,"eighty":-11.805884,"marketCap":2922031372},{"date":"2023-04-21","current":-18.52965,"twenty":-20.644026,"median":-14.496144,"eighty":-11.808405,"marketCap":4141098868},{"date":"2023-04-28","current":-17.350338,"twenty":-20.637671,"median":-14.522192,"eighty":-11.817795,"marketCap":3877540192},{"date":"2023-05-05","current":-20.292744,"twenty":-20.608621,"median":-14.540806,"eighty":-11.820768,"marketCap":4535123986},{"date":"2023-05-12","current":-18.764855,"twenty":-20.608621,"median":-14.550984,"eighty":-11.830425,"marketCap":4596657665},{"date":"2023-05-19","current":-18.602803,"twenty":-20.594096,"median":-14.562246,"eighty":-11.831705,"marketCap":4556961197},{"date":"2023-05-25","current":-19.486465,"twenty":-20.588649,"median":-14.567395,"eighty":-11.837869,"marketCap":4773423882},{"date":"2023-06-02","current":-19.241641,"twenty":-20.566861,"median":-14.631091,"eighty":-11.848868,"marketCap":4713451537},{"date":"2023-06-09","current":-19.494115,"twenty":-20.535087,"median":-14.653628,"eighty":-11.860631,"marketCap":4775298018},{"date":"2023-06-16","current":-19.94551,"twenty":-20.51693,"median":-14.700243,"eighty":-11.866344,"marketCap":4885872030},{"date":"2023-06-23","current":-20.683807,"twenty":-20.530548,"median":-14.717194,"eighty":-11.866918,"marketCap":5066726135},{"date":"2023-06-30","current":-18.556898,"twenty":-20.521469,"median":-14.735995,"eighty":-11.867493,"marketCap":4545716382},{"date":"2023-07-07","current":-17.986917,"twenty":-20.50876,"median":-14.751068,"eighty":-11.869888,"marketCap":4406093265},{"date":"2023-07-14","current":-18.530121,"twenty":-20.492419,"median":-14.775826,"eighty":-11.883169,"marketCap":4539156907},{"date":"2023-07-21","current":-18.308249,"twenty":-20.476986,"median":-14.795999,"eighty":-11.893983,"marketCap":4484806969},{"date":"2023-07-28","current":-17.684713,"twenty":-20.449751,"median":-14.806507,"eighty":-11.917488,"marketCap":4332064901},{"date":"2023-08-04","current":-18.675485,"twenty":-20.429779,"median":-14.847747,"eighty":-11.938838,"marketCap":4574765487},{"date":"2023-08-11","current":-16.822179,"twenty":-20.409807,"median":-14.877903,"eighty":-11.965282,"marketCap":4453974775},{"date":"2023-08-18","current":-16.808001,"twenty":-20.39619,"median":-14.922726,"eighty":-11.987006,"marketCap":4450220898},{"date":"2023-08-25","current":-17.499178,"twenty":-20.39289,"median":-14.955882,"eighty":-12.021492,"marketCap":4633222391},{"date":"2023-09-01","current":-18.403025,"twenty":-20.387937,"median":-15.002599,"eighty":-12.049146,"marketCap":4872532034},{"date":"2023-09-08","current":-17.65868,"twenty":-20.370771,"median":-15.005716,"eighty":-12.05623,"marketCap":4675453504},{"date":"2023-09-15","current":-18.254156,"twenty":-20.34457,"median":-15.02393,"eighty":-12.07384,"marketCap":4833116328},{"date":"2023-09-22","current":-18.498726,"twenty":-20.336915,"median":-15.038325,"eighty":-12.101,"marketCap":4897870702},{"date":"2023-09-29","current":-17.793371,"twenty":-20.329918,"median":-15.05078,"eighty":-12.110314,"marketCap":4711115333},{"date":"2023-10-05","current":-16.981682,"twenty":-20.318417,"median":-15.056803,"eighty":-12.11436,"marketCap":4496205889},{"date":"2023-10-13","current":-16.074291,"twenty":-20.302625,"median":-15.087198,"eighty":-12.118714,"marketCap":4255957776},{"date":"2023-10-20","current":-16.481908,"twenty":-20.286743,"median":-15.148339,"eighty":-12.120899,"marketCap":4363881733},{"date":"2023-10-27","current":-17.109284,"twenty":-20.27474,"median":-15.149846,"eighty":-12.125268,"marketCap":4529990780},{"date":"2023-11-03","current":-16.942692,"twenty":-20.257291,"median":-15.15932,"eighty":-12.136983,"marketCap":4485882728},{"date":"2023-11-10","current":-15.261986,"twenty":-20.237319,"median":-15.186632,"eighty":-12.142826,"marketCap":4571193788},{"date":"2023-11-17","current":-15.913257,"twenty":-20.193743,"median":-15.226852,"eighty":-12.158302,"marketCap":4766259301},{"date":"2023-11-24","current":-15.671811,"twenty":-20.168324,"median":-15.249734,"eighty":-12.181733,"marketCap":4693942330},{"date":"2023-12-01","current":-16.446982,"twenty":-20.146536,"median":-15.273621,"eighty":-12.206635,"marketCap":4926117868},{"date":"2023-12-08","current":-18.038626,"twenty":-20.120209,"median":-15.310702,"eighty":-12.223784,"marketCap":5402838953},{"date":"2023-12-15","current":-19.249037,"twenty":-20.114441,"median":-15.345894,"eighty":-12.244421,"marketCap":5765375346},{"date":"2023-12-22","current":-18.858274,"twenty":-20.094761,"median":-15.397427,"eighty":-12.255986,"marketCap":5648336038},{"date":"2023-12-29","current":-20.113163,"twenty":-20.109873,"median":-15.413482,"eighty":-12.261481,"marketCap":6024193978},{"date":"2024-01-05","current":-20.440387,"twenty":-20.111189,"median":-15.447202,"eighty":-12.270831,"marketCap":6122202505},{"date":"2024-01-12","current":-19.061598,"twenty":-20.087206,"median":-15.502485,"eighty":-12.282097,"marketCap":5709234540},{"date":"2024-01-19","current":-19.32846,"twenty":-20.064832,"median":-15.526575,"eighty":-12.296687,"marketCap":5789163823},{"date":"2024-01-26","current":-20.141755,"twenty":-20.103564,"median":-15.604871,"eighty":-12.314783,"marketCap":6032757830},{"date":"2024-02-02","current":-26.753532,"twenty":-20.133863,"median":-15.653053,"eighty":-12.324561,"marketCap":8013084121},{"date":"2024-02-09","current":-26.696296,"twenty":-20.242766,"median":-15.671811,"eighty":-12.343291,"marketCap":7995941244},{"date":"2024-02-16","current":-27.009566,"twenty":-20.315086,"median":-15.741703,"eighty":-12.355101,"marketCap":8089770067},{"date":"2024-02-23","current":-26.599075,"twenty":-20.346777,"median":-15.756821,"eighty":-12.358131,"marketCap":7966821955},{"date":"2024-03-01","current":-19.791455,"twenty":-20.39058,"median":-15.767484,"eighty":-12.362433,"marketCap":7961429494},{"date":"2024-03-08","current":-19.338793,"twenty":-20.378033,"median":-15.787476,"eighty":-12.370073,"marketCap":7779338704},{"date":"2024-03-15","current":-18.670451,"twenty":-20.346777,"median":-15.797598,"eighty":-12.386838,"marketCap":7510487534},{"date":"2024-03-22","current":-18.228483,"twenty":-20.337432,"median":-15.827712,"eighty":-12.411509,"marketCap":7332698857},{"date":"2024-03-28","current":-18.460246,"twenty":-20.335365,"median":-15.836525,"eighty":-12.412327,"marketCap":7425929505},{"date":"2024-04-05","current":-17.075054,"twenty":-20.321747,"median":-15.83959,"eighty":-12.439419,"marketCap":6868713772},{"date":"2024-04-12","current":-17.471208,"twenty":-20.305095,"median":-15.881916,"eighty":-12.458883,"marketCap":7028073135},{"date":"2024-04-19","current":-16.389647,"twenty":-20.292744,"median":-15.911669,"eighty":-12.479472,"marketCap":6592997737},{"date":"2024-04-26","current":-16.238241,"twenty":-20.262738,"median":-15.930098,"eighty":-12.504692,"marketCap":6532092446},{"date":"2024-05-03","current":-17.452189,"twenty":-20.25366,"median":-15.962149,"eighty":-12.529434,"marketCap":7020422368},{"date":"2024-05-10","current":-16.330835,"twenty":-20.226425,"median":-15.977539,"eighty":-12.570574,"marketCap":7133700477},{"date":"2024-05-17","current":-18.791543,"twenty":-20.171955,"median":-16.02345,"eighty":-12.576745,"marketCap":8208596934},{"date":"2024-05-24","current":-17.252355,"twenty":-20.162877,"median":-16.044981,"eighty":-12.588189,"marketCap":7536242672},{"date":"2024-05-31","current":-17.486471,"twenty":-20.145979,"median":-16.069505,"eighty":-12.628691,"marketCap":7638510149},{"date":"2024-06-07","current":-18.059308,"twenty":-20.138199,"median":-16.100696,"eighty":-12.670073,"marketCap":7888739081},{"date":"2024-06-14","current":-18.432897,"twenty":-20.128139,"median":-16.153211,"eighty":-12.677887,"marketCap":8051931863},{"date":"2024-06-21","current":-18.121573,"twenty":-20.120209,"median":-16.193449,"eighty":-12.678628,"marketCap":7915937878},{"date":"2024-06-28","current":-19.618421,"twenty":-20.118394,"median":-16.224679,"eighty":-12.679369,"marketCap":8569796958},{"date":"2024-07-05","current":-18.993281,"twenty":-20.114892,"median":-16.24076,"eighty":-12.706999,"marketCap":8296721036},{"date":"2024-07-12","current":-20.412921,"twenty":-20.128139,"median":-16.30313,"eighty":-12.732244,"marketCap":8916853608},{"date":"2024-07-15","current":-20.520016,"twenty":-20.138199,"median":-16.303907,"eighty":-12.734601,"marketCap":8963635539},{"date":"2024-08-02","current":-19.57359,"twenty":-20.13731,"median":-16.304683,"eighty":-12.736958,"marketCap":8550213824},{"date":"2024-08-09","current":-16.530842,"twenty":-20.122025,"median":-16.304683,"eighty":-12.780687,"marketCap":8218936172},{"date":"2024-08-16","current":-17.608355,"twenty":-20.117486,"median":-16.330835,"eighty":-12.794946,"marketCap":8754662593},{"date":"2024-08-23","current":-17.54101,"twenty":-20.113163,"median":-16.355854,"eighty":-12.79665,"marketCap":8721179691},{"date":"2024-08-30","current":-17.796919,"twenty":-20.109873,"median":-16.382189,"eighty":-12.811343,"marketCap":8848414716},{"date":"2024-09-06","current":-25.164413,"twenty":-20.118394,"median":-16.416684,"eighty":-12.816444,"marketCap":12511444119},{"date":"2024-09-13","current":-28.394781,"twenty":-20.157687,"median":-16.444961,"eighty":-12.828575,"marketCap":14117544202},{"date":"2024-09-20","current":-29.138673,"twenty":-20.231872,"median":-16.459942,"eighty":-12.887955,"marketCap":14487398378},{"date":"2024-09-27","current":-27.725527,"twenty":-20.308425,"median":-16.491202,"eighty":-12.905778,"marketCap":13784799140},{"date":"2024-10-04","current":-27.635961,"twenty":-20.356246,"median":-16.541596,"eighty":-12.90971,"marketCap":13740268202},{"date":"2024-10-11","current":-27.765334,"twenty":-20.401715,"median":-16.572344,"eighty":-12.931873,"marketCap":13804590668},{"date":"2024-10-18","current":-28.762995,"twenty":-20.436258,"median":-16.616599,"eighty":-12.959362,"marketCap":14300615834},{"date":"2024-10-25","current":-27.944465,"twenty":-20.506036,"median":-16.648008,"eighty":-12.966906,"marketCap":13893652543},{"date":"2024-10-31","current":-26.399458,"twenty":-20.557783,"median":-16.667668,"eighty":-12.971839,"marketCap":13125493869},{"date":"2024-11-08","current":-25.214663,"twenty":-20.644026,"median":-16.733567,"eighty":-12.983254,"marketCap":12800173274},{"date":"2024-11-15","current":-22.754576,"twenty":-20.684289,"median":-16.791289,"eighty":-12.992224,"marketCap":11551315083},{"date":"2024-11-22","current":-21.701305,"twenty":-20.822787,"median":-16.813646,"eighty":-12.995724,"marketCap":11016624300},{"date":"2024-11-29","current":-23.162135,"twenty":-20.907297,"median":-16.822179,"eighty":-13.001558,"marketCap":11758211749},{"date":"2024-12-06","current":-22.10641,"twenty":-21.101995,"median":-16.843442,"eighty":-13.013917,"marketCap":11222274601},{"date":"2024-12-13","current":-21.573636,"twenty":-21.189632,"median":-16.875347,"eighty":-13.021971,"marketCap":10951813297},{"date":"2024-12-20","current":-21.166077,"twenty":-21.226278,"median":-16.929408,"eighty":-13.028697,"marketCap":10744916630},{"date":"2024-12-27","current":-21.060504,"twenty":-21.23055,"median":-16.99586,"eighty":-13.041117,"marketCap":10691322915},{"date":"2025-01-03","current":-20.451621,"twenty":-21.213463,"median":-17.04371,"eighty":-13.056938,"marketCap":10382224281},{"date":"2025-01-10","current":-19.901661,"twenty":-21.217735,"median":-17.069181,"eighty":-13.068397,"marketCap":10103038418},{"date":"2025-01-17","current":-21.563816,"twenty":-21.235455,"median":-17.105654,"eighty":-13.074127,"marketCap":10946827835},{"date":"2025-01-24","current":-22.090451,"twenty":-21.246134,"median":-17.110391,"eighty":-13.076047,"marketCap":11214173226},{"date":"2025-01-31","current":-22.575348,"twenty":-21.285242,"median":-17.144092,"eighty":-13.080045,"marketCap":11460330404},{"date":"2025-02-07","current":-21.854754,"twenty":-21.34285,"median":-17.212623,"eighty":-13.093733,"marketCap":11094522142},{"date":"2025-02-14","current":-20.5842,"twenty":-21.34285,"median":-17.248595,"eighty":-13.124157,"marketCap":10449528016},{"date":"2025-02-21","current":-20.247841,"twenty":-21.305793,"median":-17.268422,"eighty":-13.140798,"marketCap":10278775948},{"date":"2025-02-28","current":-20.59955,"twenty":-21.28584,"median":-17.296089,"eighty":-13.151072,"marketCap":9556687584},{"date":"2025-03-07","current":-20.763303,"twenty":-21.279088,"median":-17.346779,"eighty":-13.166601,"marketCap":9632656941},{"date":"2025-03-14","current":-20.266494,"twenty":-21.271161,"median":-17.38221,"eighty":-13.175744,"marketCap":9402173638},{"date":"2025-03-21","current":-20.666162,"twenty":-21.261605,"median":-17.434922,"eighty":-13.187616,"marketCap":9587590374},{"date":"2025-03-28","current":-19.642013,"twenty":-21.246879,"median":-17.48489,"eighty":-13.202598,"marketCap":9112459988},{"date":"2025-04-04","current":-8.481841,"twenty":-21.24317,"median":-17.461699,"eighty":-13.166601,"marketCap":3934955168},{"date":"2025-04-11","current":-7.782422,"twenty":-21.239771,"median":-17.384971,"eighty":-13.08988,"marketCap":3610475880},{"date":"2025-04-17","current":-8.082173,"twenty":-21.237354,"median":-17.363411,"eighty":-13.071978,"marketCap":3749538432},{"date":"2025-04-25","current":-9.578153,"twenty":-21.23055,"median":-17.338853,"eighty":-13.021611,"marketCap":4443563575},{"date":"2025-05-02","current":-9.79882,"twenty":-21.209423,"median":-17.273877,"eighty":-12.990005,"marketCap":4545937129}],"updateTime":1746468870546}}}